key: cord-0788590-2r7gl7vk
authors: McClain, Jesse V.; Chance, Elisha A.; Polcha, Gregory M.
title: Letter to the Editor Regarding “Incidence of Acute Ischemic Stroke and Rate of Mechanical Thrombectomy During the COVID-19 Pandemic in a Large Tertiary Care Telemedicine Network”
date: 2020-09-23
journal: World Neurosurg
DOI: 10.1016/j.wneu.2020.06.220
sha: 62ab746299796bbe6d9cef5f66b0f8e200fe4e6e
doc_id: 788590
cord_uid: 2r7gl7vk

nan

Letter to the Editor Regarding "Incidence of Acute Ischemic Stroke and Rate of Mechanical Thrombectomy During the COVID-19 Pandemic in a Large Tertiary Care Telemedicine Network" LETTER: W e read the recently published article by Sweid et al 1 with great interest and enthusiasm. They investigated and compared key metrics related to their stroke service and found that thrombectomy procedures increased within their telestroke network during the COVID-19 pandemic. 1 Interestingly, they reported that while their overall admissions declined, their thrombectomy cases increased by 50% and 25% of the thrombectomy cases during March and April 2020 were COVID-19 positive. 1 This raises the question, "How many ischemic stroke cases actually had COVID-19 but were never tested because they lacked classic symptoms?" Thromboembolic complications are now known to be common in COVID-19 patients. [1] [2] [3] [4] [5] [6] New data are rapidly emerging regarding neurologic manifestations and complications of COVID-19. [1] [2] [3] [4] [5] [6] Pooled proportions reveal that stroke occurs in approximately 3% of COVID-19 patients. 2 A recent systematic review by Ghannam et al 3 indicated that ischemic stroke was the most common neurologic complication of COVID-19, and large vessel occlusions comprised the majority. 3 Investigations by Jain et al 4 and Lodigiani et al 5 reported that thromboembolic events were often initial manifestations of COVID-19, rather than a complication after the onset of respiratory symptoms. Oxley's group 6 described 5 patients, younger than 50, who presented with symptoms of large vessel ischemic stroke and subsequently tested positive for COVID-19.

At our institution, an accredited Primary Stroke Center and Level I Trauma Center in northeast Ohio, we noticed an unusual increase in the use of tissue plasminogen activator (tPA) and mechanical thrombectomy (MT) during the COVID-19 pandemic as well. From February through May 2020, the stroke service at our facility saw an 80% increase in tPA and MT cases compared with the prior year. From February through May 2019, there were 27 tPA cases and 6 MT cases. In 2020, the stroke service saw 49 tPA and 11 MT cases from February through May. Unlike other investigations reported in the literature, most of our cases during those months did not meet the facility's COVID-19 testing criteria because they did not present with cough, fever, and shortness of breath. However, we suspected that many were COVID-19 positive based on occupation, travel history, or young age with lack of other stroke risk factors. On the basis of other reports and experiences with COVID-19, 1-6 we suspect the infection declared itself as an ischemic stroke in a proportion of our patients rather than the known respiratory symptoms.

To explore whether our 80% increase in tPA and MT cases might be connected to the COVID-19 pandemic, we downloaded the state's COVID-19 data 7 and compiled a figure to visually compare with our institutional tPA/MT data ( Figure 1) . Visually, it appears that as the COVID-19 curve increased, our tPA and MT cases steadily increased. Yet we acknowledge that this figure cannot assess causality. Our intention is to add our experience to the rapidly growing body of knowledge about thromboembolic manifestations of COVID-19. The increase in tPA and MT cases at our facility may not be directly associated with COVID-19 infections, but our experience is not unique. [1] [2] [3] [4] [5] [6] We recommend that providers consider COVID-19 testing when patients present with ischemic stroke, especially if they have no other medical risks.

Stroke has been a well-recognized leading cause of death and disability in the United States for decades. As Sweid et al 1 WORLD NEUROSURGERY 142: 561-562, OCTOBER 2020 www.journals.elsevier.com/world-neurosurgery income. These socioeconomic factors, along with other obstacles to receiving usual medical care during pandemic shutdowns, may have contributed to the subsequent increase in strokes. Future research could examine an association between the rates of stroke and COVID-19 in diverse populations on a national or global scale.

Incidence of acute ischemic stroke and rate of mechanical thrombectomy during the COVID-19 pandemic in a large tertiary care telemedicine network

Thrombosis risk associated with COVID-19 infection. A scoping review

Neurological involvement of coronavirus disease 2019: a systematic review

COVID-19 related neuroimaging findings: a signal of thromboembolic complications and a strong prognostic marker of poor patient outcome

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in

Large-vessel stroke as a presenting feature of Covid-19 in the young

Ohio Department of Health. COVID summary data

The authors acknowledge Erika M. Mikula, stroke coordinator, for providing the institutional aggregate data.https://doi.org/10.1016/j.wneu.2020.06.220.